JUL 02, 2018 5:16 AM PDT

AF Treatment Zaps Faulty Heart Tissue

WRITTEN BY: Kara Marker

Treating atrial fibrillation (AF), the most common type of arrhythmia, with what was previously a last-resort therapeutic approach will help reduce the risk of death and stroke in the long-run. From the University of California - Davis Health System, scientists show how cardiac ablation in addition to medication can be beneficial for AF patients.

Nearly three million Americans are living with atrial fibrillation (AF).

Catheter-based cardiac ablation is currently only recommended for when drugs prescribed to treat AF aren’t working or are poorly tolerated. Nearly three million Americans have AF, a condition where the heart beats irregularly when the upper chambers of the heart, the atria, quiver while sending blood into the lower chambers of the heart, the ventricles.

Patients with AF may experience lightheadedness, fatigue, shortness of breath, and chest pain, indicating their increased risk of blood clots, heart failure, stroke, and death. Drugs prescribed to treat AF control the heart rate and rhythm and minimize the risk of blood clot formation, but the new study shows that cardiac ablation may be beneficial in the early stages of the disease as well.

"Less than 2 percent of patients undergo ablation early in the course of [AF] when the procedure can be most beneficial," explained lead author Uma Srivatsa. "Our study shows that ablation may be considered as a primary treatment for everyone with the condition."

Cardiac ablation is a process where long, flexible tubes called catheters enter the body through a blood vessel in the groin and travel up to the heart to deliver their energy, in the form of either heat or extreme cold. This energy scars or destroys the heart tissue responsible for quivering in the atria. Conducting cardiac ablation with a catheter through a groin blood vessel makes a less invasive procedure than if it were done via open heart surgery.

In the past, studies of cardiac ablation showing that the procedure was not safe or beneficial enough to conduct in the early stages of AF produced inconsistent results. Additionally, after a closer look at their methodology, researchers found that many studies limited the diversity of their study subjects and conducted controversial data collection.

In contrast, the new study evaluates AF treatment outcomes over a long period of time, collecting data from a large population of multi-ethnic participants with similar health statuses, eliminate confounding variables. Researchers compared two study groups of four thousand diverse AF participants. One group was treated with ablation, and one was not. Other AF factors were nearly the same.

After 30 days, the group who received cardiac ablation were less likely to die and less likely to have a stroke.

The present study was published in the journal Circulation: Arrhythmia and Electrophysiology.

Sources: American Heart Association, Mayo Clinic, University of California - Davis Health System

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
SEP 04, 2019
Drug Discovery & Development
SEP 04, 2019
Re-Evaluating a Popular Heart Failure Drug
A recent study found that the popular heart drug--sacubitril/valsartan—holds positive effects on the structure and function of the failing heart. Spe...
OCT 03, 2019
Cardiology
OCT 03, 2019
What is Polycythemia Vera?
Polycythemia Vera (PV) is a slow-growing cancer of the blood. The cancer is characterized by an overproduction of blood cells within the bone marrow. Too m...
OCT 18, 2019
Cardiology
OCT 18, 2019
Find the Motivation to Exercise with Imagery
Those involved in professional sports have a lot on their plate. From fitting in intense regular workouts to getting adequate sleep, to eating a healthy di...
OCT 30, 2019
Genetics & Genomics
OCT 30, 2019
Disruptions in Mitochondrial Quality Control Can Cause Heart Disease
Researchers have learned why mutations in the ANT gene lead to heart problems....
NOV 18, 2019
Cannabis Sciences
NOV 18, 2019
Frequent Marijuana Use Linked with Stroke and Arrhythmia
Research from two new preliminary studies presented at the American Heart Association’s (AHA) annual Scientific Sessions this week warned of the heal...
NOV 19, 2019
Drug Discovery & Development
NOV 19, 2019
Experimental Cholesterol-Lowering Drug
A recent study shows that patients who take a maximum dose of statin drugs in addition to a twice-yearly injection of the experimental cholesterol-lowering...
Loading Comments...